Xtandi 80 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCPH2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,498
Award facts
- Contract value 100% obligated
- $13,498.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,498.18 to DMS Pharmaceutical Group Inc. for 60 tablets of Xtandi 80 mg on January 14, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price delivery order with no set-aside designation. The delivery is scheduled for completion by January 15, 2026, with performance taking place at the contractor's Park Ridge facility.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical supply support to Department of Defense healthcare facilities worldwide. The underlying IDC, valued at $499,999,999 and effective through December 31, 2036, authorizes DLA to issue delivery orders for branded and generic prescription medications, biologics, and medical consumables. Xtandi, an oncology treatment, aligns with DMS Pharmaceutical Group's established product portfolio of specialty pharmaceuticals supplied to federal military medical systems.
Quick answers
Who was awarded contract SPE2DR26FCPH2?
SPE2DR26FCPH2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FCPH2 worth?
The government has obligated $13,498 on SPE2DR26FCPH2.
Is contract SPE2DR26FCPH2 an order under another contract?
Yes. SPE2DR26FCPH2 is a delivery order under SPE2DR25D9131, an indefinite delivery contract.
Was contract SPE2DR26FCPH2 competed?
The extent of competition for SPE2DR26FCPH2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award